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La absorción de luz por una molécula llamada fotosensibilizador (PS) en presencia de oxígeno molecular 
desencadena la generación de especies reactivas de oxígeno (ROS), que en un medio biológico son capaces 
de degradar las moléculas objetivo. Este efecto se denomina acción fotodinámica (PDA) y es la raíz de la 
terapia fotodinámica (TFD), que en los últimos años se convirtió en una herramienta muy útil y versátil 
para inactivar tanto a las células dañinas como a los patógenos. Con el desarrollo de estructuras 
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supramoleculares funcionalizadas con propiedades fotosensibilizantes, hoy en día los horizontes de la TFD 
en aplicaciones antitumorales y antimicrobianas han mejorado y ampliado enormemente. En este artículo 
de revisión, discutimos los conceptos básicos de los procesos de fotosensibilización y TFD, revisando 
algunos de los avances más recientes en aplicaciones emergentes de fotosensibilizadores supramoleculares 
contra patógenos resistentes a múltiples fármacos, así como en tratamientos teranósticos del cáncer, donde 
se realiza con el mismo conjunto supramolecular tanto el diagnóstico como la terapia.     
 
Abstract 
Light absorption by a molecule called photosensitizer (PS) in the presence of molecular oxygen triggers the 
generation of reactive oxygen species (ROS), which can degrade target molecules in a biological milieu. 
This effect is called photodynamic action (PDA) and is the root of photodynamic therapy (PDT), which in 
recent years became a very useful and versatile tool for killing both harmful cells and pathogens. With the 
development of functionalized supramolecular structures with photosensitizing properties, nowadays the 
horizons of PDT in antitumoral and antimicrobial applications have been greatly improved and expanded. 
In this review article, we discussed the basics of the photosensitization and PDT processes, reviewing some 
of the most recent advances on emerging applications of supramolecular photosensitizers against multi-
drug resistant pathogens as well as in cancer theranostic treatments, where both diagnostic and therapy is 
performed with the same supramolecular ensemble. 
 
Palabras Clave: fotosensibilización, terapia fotodinámica, fotosensibilizadores supramoleculares, 
antimicrobianos, anticancerígenos. 
 




1. Basics of photosensitization 
Solar light is a ubiquitous vector that promotes life on our planet, mainly by bacterial and plant 
photosynthesis. However, the photon flux incoming from the Sun also induces other 
photophysical and photochemical processes, such as visual and non-visual photoreception, 
photomovement, photoionization, photosensitization, photodegradation, environmental 
photochemistry, and photobiology, among others 1. From all of them, from a biological point of 
view, photosensitization is particularly relevant due to their involvement from energy conversion 
to cell killing processes 2.  
According to the "Gold Book" of the International Union of Pure and Applied Chemistry 
(IUPAC), the term photosensitization refers to the process by which a photochemical or 
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photophysical alteration occurs in one molecular entity as a result of initial absorption of 
radiation by another molecular entity called a photosensitizer (PS) 3. Hence, a very vast number 
of natural and artificial photochemical and photobiological processes are easily initiated through 
photosensitized mechanisms by the absorption of lower energy photons of the visible or near-
infrared region, i.e. above 400 nm, improving the utilization of the solar irradiation that impacts 
the Earth´s surface 1, 4.  
Scheme 1 summarizes the photophysical and photochemical pathways involved during the 
photosensitization process of a PS molecule. The first step is the absorption of light by the ground 
state of the PS to finally produce the triplet excited state (3PS*) by intersystem crossing from the 
lowest singlet excited state (1PS*). Due to the spin-forbidden nature of the S0  T1 transition, 
the 3PS* is a long-lived species (usually in a time-scale from hundreds of nanoseconds to the 
millisecond in fluid solutions) allowing a larger reactivity during its lifetime 5. 
 
Scheme 1. Photophysical and photochemical pathways involved in photosensitized processes. See text for 
abbreviation meaning. 
 
The primary photochemical reaction of 3PS* with Q can produce radical/radical ion species by 
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transfer or electron-transfer reactions can take place in both directions, the 3PS* acts most 
commonly as an oxidant. Thus, under aerobic conditions, the  neutral or anion radicals PS•/PS• 
can react with molecular oxygen 3O2 to generate anion superoxide (O2•) and the PS ground state 
molecule (type I mechanism) 6, 7. In turn, O2• can produce other reactive oxygen species (ROS) 
in subsequent secondary steps, such as hydroperoxyl radical (HO2•), hydroxyl radical (HO•), and 
hydrogen peroxide (H2O2), as well as other oxidants involving a substrate R, e.g. peroxyl radicals 
(ROO•) and alkoxyl radicals (RO•) 6-8.  
Conversely, the diffusion-controlled quenching of 3PS* by 3O2 through an efficient down-hill 
energy-transfer process (kqO2  109 M-1s-1) produces singlet molecular oxygen (1O2) and the 
ground state of the PS. 1O2 is the lowest excited state of 3O2, with  an  energy gap  of                      
22.5 kcal mol-1, showing in solution a lifetime ranging between hundreds of ns to several ms 
depending on the solvent nature, while in gas phase up to several seconds 9. Since 1O2 is an 
electrophilic species, it can react with electron-rich biomolecules such as guanine (but not with 
other nucleic acids), unsaturated lipids, and amino acid residues to form mainly endoperoxides 
from [4 + 2] cycloadditions, dioxetanes from [2 + 2] cycloadditions, hydroperoxides from “ene” 
reactions or phenol oxidations, and sulfoxides from sulfide derivatives 7,10,11. The oxidation of 
target molecules by the photosensitized generation of 1O2 is termed the type II mechanism 6,7.  
On the other hand, the 3PS* can also react with Q to form a stable product (P) 8,12. This oxygen-
independent process is sometimes denominated as a type III reaction, but strictly it cannot be 
considered as a photosensitized reaction since the PS molecule is depleted 7, 13. 
Hence, both type I and type II photosensitization mechanisms drive to the final formation of 
highly reactive and harmful ROS species that react with biological molecular targets (e.g. DNA, 
lipids, proteins) inducing damage of subcellular organelles, which in turn can lead to tissue 
injury, inflammation, and finally cell killing 14-17. Usually, type II mechanism prevails and the 
main ROS generated is 1O2, albeit the type I pathway can eventually result in the generation of 
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the highly toxic hydroxyl radical (HO•) from the secondary transformation of H2O2 by Fenton 
reaction with iron (II) 18.  
Thus, the term “photodynamic action” (PDA) refers exclusively to oxygenation reactions of 
organic substrates that only occurs under the illumination of the PS added to the reaction mixture, 
but not in darkness, and that the PS is not consumed during these reactions 18. Hence, any          
cell-killing process produced by the combined use of light, photosensitizer, and 3O2 is 
denominated photodynamic therapy (PDT), while the use of the term “oxygen-independent 
photodynamic action” to describe the type III reaction is inaccurate 7. 
 
2. Molecular and supramolecular PS 
Molecular photosensitization is a field of high current interest in several scientific and 
technological areas. Figure 1A shows the exponential growth of the number of published articles 
since 1985 reported by the Scopus® database obtained by using “molecular photosensitizer” as 
the search term. Hundreds of organic and inorganic molecules have been used as PS in organic 
synthesis, energy conversion, clinical and environmental applications among others 19-21. 
Many natural and artificial PS have been tested in PDT, mainly those with high efficiency of 1O2 
generation (type II mechanism) 22, 23, albeit type I oxidation processes are also relevant in the 
modification of nucleic acids 7, 24, 25 and proteins 26-30. 
Typical organic PS include compound groups like tetrapyrroles (e.g. porphyrins, chlorins, 
phthalocyanines); organic dyes (e.g. xanthenic and phenothiazines derivatives such as rose bengal 
(RB) and methylene blue (MB), respectively, boron-dipyrromethenes BODIPYs, cyanines, and 
coumarins); quinones (anthraquinones and hypericins), isoalloxazines derivatives or flavins 
(lumiflavin, riboflavin, flavin mononucleotide), phenalenones, biological molecules (proteins, 
chlorophylls, verdins, vitamins, etc.) 1, 2, 14, 17, 19, 22, 23, 31, 32 . Chart 1 shows some of these structures, 
but most of them can be found in the preceding citations. 
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Figure 1. Number of the photosensitizer (PS)-related papers published since 1985 obtained from Scopus® 
database by searching in the title, abstract, and keyword sections the following terms: (A) “molecular 
photosensitizer” and ‘‘supramolecular photosensitizer’’; and (B) ‘‘antimicrobial photosensitizer’’ and 
“theranostic photosensitizer”. 
 
An ideal molecular PS for photodynamic applications is expected to fulfill several photophysical 
and photochemical features, such as a high molar absorptivity coefficient, mainly in the visible 
and near-infrared (NIR) light spectrum, efficient intersystem crossing leading to high excited 
triplet quantum yields (T  0.2), with larger triplet-state energy than that of 1O2                                
(i.e.  22.5 kcal mol-1) and long lifetime (s) to increase the probability of interaction with triplet 
molecular oxygen for the subsequent efficient ROS generation 15, 31, 33. Figure 2 shows the 
absorptivity spectra of some typical organic molecular PS covering the visible region together with 
their singlet oxygen quantum yield average values in fluid solutions (). Furthermore, PS 
molecules are expected to be photo-stable and no cytotoxic in the absence of light, together with 
the ability to interact with cell targets 15, 33. Nevertheless, all these requirements are very difficult 
to be satisfied by a simple molecule, and hence new strategies are required to obtain PS systems 
able to satisfy multiple functions 34-42. 
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Chart 1. Molecular structures of some selected organic photosensitizers. 
 
Figure 2: Structure and absorptivity spectra and singlet oxygen quantum yield () values of typical 
molecular PS covering the visible region of the electromagnetic spectrum. 
 
Regarding this, supramolecular chemistry can afford practical solutions for the development 
and design of PS systems with multiple desired functionalities. The concept behind 
supramolecularity is to obtain molecular systems of higher complexity by the association of two 
or more chemical species held together due to intermolecular forces 43, 44. The association driving 
forces include van der Waals, electrostatic, hydrogen bonding, hydrophobic interactions, etc., 
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some of which are often cooperatively working in one supramolecular complex 43, 44. Even more, 
in many cases, the supramolecular complex owns new advantageous properties missing in the 
individual components 44. Nature is an inspiration source of supramolecular examples, for 
instance, the building of three-dimensional structures of proteins, DNA, and phospholipid 
membranes, among others 45, 46. The development of facile approaches to fabricate submicron-
structured assemblies allows to obtain supramolecular structures with high specificity, selective 
targeting and/or signaling, generation or scavenging of ROS (pro- or antioxidant function, 
respectively), sensitive to external stimuli (pH, ionic strength, light, temperature, etc.) 45-47. 
A new article search in Scopus® using the term “supramolecular photosensitizer” leads to a fewer 
number of articles than the former search for “molecular photosensitizer” in the same period, but 
with almost twice-faster growth in the last decade (Figure 1A). In particular, photosensitizing 
processes using supramolecular devices are being intensively explored, especially for medical 
and energy conversion applications 38, 48, 49.  
Usually, the bottom-up strategy is selected for the building up of the supramolecular PS, using a 
large diversity of nanomaterials (e.g. metal nanoparticles, fullerenes, carbon nanotubes, 
semiconductors, nanocellulose, etc) 35, 37, 40, 50-54, biomolecules as proteins 26, 55-58, and self-
assembled nano/micro-systems (micelles, vesicles, multilayers, microcapsules, polymers, 
peptides, etc.) 24, 53, 59-63. Chart 2 shows a pictorial representation of some representative 
supramolecular PS systems. 
Figure 1B also shows the evolution of reported articles on photosensitization oriented to 
antimicrobial 64-67, and cancer theranostic applications 68-70. The term theranostics implies the 
combination of therapy + diagnostic functions by a single composite and is a new field of 
medicine allowing specific targeted diagnostic and efficient therapy 71. Hence, supramolecularity 
became a very helpful tool for the design of photosensitizing systems with multiple functions 
and/or properties. 
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Chart 2. Schematic representation of some supramolecular PS systems 
 
Both applied research areas have blasted within the last two decades, probably associated with 
two world-wide concerns: i) the increase of microbial resistance to the common antibiotics used 
to treat infections caused by bacteria, fungi, viruses, and parasites, that has become one of the 
leading causes of morbidity and mortality 72-74, and ii) the need of painless and less invasive 
cancer treatments 75. For the latter, the design of supramolecular PS became a very interesting 
challenge oriented to obtain theranostic agents with multiple functions such as specific targeting 
to the neoplastic cells, tracking through the body tissues by exploiting the intrinsic 
luminescence/photoacoustic/magnetic responses, and with efficient PDT in the treated cells 76-78. 
This application field shows a promising horizon for PDT as illustrated by the increase of 
reported articles since 2010 (Figure 1B). 
 
3. Antitumoral vs. antimicrobial photodynamic treatments 
Despite the PDA was discovered more than a hundred years ago by Oscar Raab 79, who found 
that Paramecium spp. protozoans were killed after staining with acridine orange and subsequent 
exposure to bright light, it was not until a quarter of a century ago that photodynamic therapy 
(PDT) was clinically approved for the treatment of a small number of selected tumors 15, 33. 
Nowadays, its application has been tremendously expanded to include health specialties such as 
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cardiology, urology, immunology, ophthalmology, dentistry, dermatology, and                  
cosmetics 15, 33, 80, 81. Hence, the PDT term was initially coined to describe the minimally invasive 
therapeutic modality used for the selective treatment of a variety of neoplastic and non-neoplastic 
diseases 15, 33. In PDT, the photo-generated cytotoxic species induce the killing of the target cells 
by different death mechanisms, e.g. necrosis, apoptosis, and autophagy 82.  
Most effective anti-cancer PS molecules are relatively lipophilic compounds, with little or no 
overall positive or negative charges, so they can rapidly diffuse towards subcellular membrane 
structures such as mitochondria and endoplasmic reticulum (ER) of tumor cells. Nevertheless, 
for more polar PS, slower incorporation by endocytosis can be expected 15. 
The successful utilization of an anticancer PS depends on several factors: a) good light-absorbing 
properties in the “phototherapeutic window” located between 650 and 1300 nm, where the 
absorption and scattering of light by tissues is minimal; b) large capability of 1O2 generation 
close to the target biomolecules or organelles in the treated cells or tissues, considering the short 
lifetime (ns to s) of this species; c) selective up-take of the PS into neoplastic cells to minimize 
non-desired toxic effects on healthy cells; and d) photobleaching capability (i.e. light-mediated 
destruction of the PS) since some new studies suggest that this phenomenon can avoid undesired 
over-treatment effects 14, 17, 36, 54, 83.  
Most PS used in PDT show absorption bands in the far-red and NIR spectral regions for deeper 
tissue penetration 17, 31, 33, 81, 83. Cyclic tetrapyrrolic structures as porphyrins and their analogs, 
chlorins, bacteriochlorins, phthalocyanines, etc. absorb light in the “phototherapeutic window” 
where tissue components such as hemoglobin and water are poor light absorbers 31. 
The development of high power NIR lasers has overcome the poor or no light absorption by PS 
in the phototherapeutic window, i.e. PS with absorbing properties at the UVA and blue-light 
edges, through a two-photon excitation process allowing deeper penetration in the tissue, 
enhancement of the three-dimensional space selectivity, and less PS photobleaching, improving 
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the application of PDT in precise cancer treatment 84-86. Furthermore, two-photon imaging was 
successfully integrated with PDT to diagnose diseases, to guide and monitor the treatment, and 
to assess the success of therapy (i.e. theranostic action) 84-86. 
Another application field of PDT was prompted by the increasing challenge of antimicrobial 
resistance 72-74. The so-called ‘‘ESKAPE’’-pathogens (Enterococcus faecium, Staphylococcus 
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and 
Enterobacter strains) are one of the main current threats to public health for they have become 
resistant to almost all kinds of available antibiotic treatments 73. As for antifungal drugs, the 
development of resistance against all drug classes has been reported in Candida and Aspergillus 
species such as Candida glabrata, Candida auris, and Aspergillus fumigatus 87. Nowadays, with 
the recent COVID-19 outbreak, more scientific research efforts on the efficacy of photosensitized 
and PDT methods to combat the SARS-CoV-2 virus is needed, but until now, few reported 
articles about PDT methods applied to treat COVID-19 can be found 88.  
Moreover, several microorganisms, such as bacteria, fungi, green algae, cyanobacteria, and 
lichen, possess the ability to grow in biofilm ecosystems rather than as planktonic single-species 
cultures, where they are usually incorporated in a matrix of extracellular polymeric substances 
(EPS) auto-produced by the microorganisms. Biofilm communities have developed resistance 
mechanisms that act synergistically, making them even less susceptible to antibiotic treatments 
89, 90. These mechanisms include, but are not limited to, slow penetration of antimicrobial agents 
through the biofilm matrix and interaction with its components, reduced growth rates, the 
formation of a sub-population of “persister cells”, the quorum-sensing systems, and the inter-
species propagation of antibiotic resistance through horizontal gene transfer 74, 89, 91. For the 
above mentioned, and considering that 80% of human infections are caused by biofilms 92, the 
search for treatments that allow the eradication of biofilms has become a key issue.  
In this context, antibacterial photodynamic therapy (APDT) was outlined as a suitable alternative 
antimicrobial treatment to deal with the antibiotic-resistance issue 16, 35, 72, 74, 80, 93. One advantage 
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of APDT over conventional antibiotic treatments is its unspecific killing mechanism since it 
involves the generation of ROS that can react with a wide variety of molecular components in 
the pathogen, with the additional potential that the PS can behave as a broad-spectrum 
antimicrobial agent. Thus, the possibility that microorganisms generate resistances through 
random mutations becomes extremely unlikely. 
In general terms, PSs for antimicrobial applications do not need to absorb light in the 
“phototherapeutic window” as in the case of anti-cancer PSs, since the superficial nature of the 
microbial infections and contaminations does not require a deep light penetration, being also very 
efficient the PS molecules absorbing blue-light 22, 23, 67, 93. Besides, antimicrobial PS are expected 
to be photo-stable, mainly in the case of immobilized PS intended to be reutilized 20, 34, 41, 51,  lack 
dark toxicity and to be active within an appropriate concentration range, among other parameters 
involved in the photodynamic inactivation of pathogens to avoid harming eukaryotic mammalian 
cells 80. Additional structural features of antimicrobial PS should be considered regarding their 
ability to interact with microbial targets. Molecular photosensitizers generally consist of planar 
-conjugated aromatic structures, a prerequisite for light absorption in the visible and NIR 
regions. However, for this reason, these types of molecules tend to be hydrophobic and prone to 
aggregation, and hence self-quenching processes of the excited states of the PS constrains their 
applicability on APDT in aqueous media 20, 34, 41. 
Furthermore, for the same PS, APDT efficiency can be different among microbial agents, mainly 
due to their variable cell surface structures. A good antimicrobial PS must photo-induce the 
reduction of the colony-forming unit (CFU) by at least 3 log units. Positively charged PSs have 
a broader action spectrum, being able to inactivate both Gram (+) and Gram () bacteria, as well 
as pathogenic yeasts 16, 64, 80, 94. Hence, Gram (+) bacteria and yeasts are the most susceptible to 
APDT, as they are also affected by neutral and negatively charged PS molecules. Moreover, the 
porosity of Gram (+) outer wall, located outside the cytoplasmic membrane, allows the passage 
of complex nutrients with molecular weights between 30–60 KDa, so they are as well permeable 
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to supramolecular PSs within this size range 95. In contrast, Gram () bacteria have an additional 
asymmetric and highly organized outer membrane to which porins, lipopolysaccharide, and 
lipoprotein constituents bestow a high negative charge density. This extra barrier constrains cell 
permeability, letting only small hydrophilic molecules (up to ~700 Da) pass through 96.  
For the above mentioned, the impartment of positive charges in a PS proved to be a successful 
strategy to improve antimicrobial photodynamic activities of all kind of PS families 
(phenothiazidium dyes, porphyrins, phthalocyanines, flavins, among others) 16, 97. An illustrative 
example is represented by a water-soluble phenalen-1-one derivative, i.e. (2-((4-
pyridinyl)methyl)-1H-phenalen-1-one chloride) termed SAPYR, Chart 1 98. This cationic 
phenalenone derivative showed a similar 1O2 quantum yield close to one, as the anionic derivative 
PNS [1H-Phenalen-1- one-2-sulfonic acid] 99. However, PNS did not produce APDT action 
because of its negative charge, while the positively charged pyridinium-methyl moiety in 
SAPYR facilitated its incorporation in bacteria, allowing a successful APDT for inactivation of 
a polybacteria biofilm  in a single treatment, with efficacy of ≥ 99.99% 98. 
 
4. Antitumoral supramolecular PS  
Most of anti-cancer PDT difficulties that could not be resolved by a single molecular PS have 
been overcome by combining concepts of supramolecular chemistry, nanotechnology, and 
photophysics to obtain new supramolecular PS systems with dual or multiple functions, e.g. 
imaging, specific recognition and attaching to cancer cells, drug/PS transport and controlled 
delivery, ROS generation, etc. 37, 54, 68, 69, 77, 78, 100-105.  
The role of supramolecular and nanocomposites structures to build multifunctional theranostic 
PSs using metal nanoparticles, carbon nanotubes, carbon quantum dots, fullerenes, titanium 
dioxide, polymeric dendrimers, vesicles, microbubbles, graphene, mice, silica nanoparticles, 
nanogels, etc., have been extensively described in several recent reviews 17, 34, 37, 38, 68, 83,100,105-107.  
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Among the diagnostic techniques used are the optical microscopy (OM), photoacoustic image 
(PAI), computed tomography (CT), positron emission tomography (PET), single-photon 
computed tomography (SPCT), magnetic resonance imaging (MRI), ultrasound (US),                    
etc. 68, 77, 78, 84, 103, 108-110. Some of the most recent examples of theranostic supramolecular PS are 
discussed in the following paragraphs.  
Chlorin e6 (Ce6) was loaded onto superparamagnetic iron oxide (SPION) nanoparticles via an 
oil-in-water emulsion 77. The Ce6-SCs nanocomposite of 92 nm of size showed high solubility 
and excellent stability under physiological conditions. The enhanced permeability and retention 
achieved by this supramolecular formulation led to its selective accumulation within tumors, as 
observed by magnetic resonance (MR) and fluorescence dual-mode imaging following 
intravenous injection of the nanocomposite in a murine tumor model. After Ce6-SCs 
administration, PDT was performed through the excitation of Ce6 by a 665 nm laser. A high 
singlet oxygen generation was observed leading to a significant delay of tumor growth in mice. 
Wu et al. 102 tested a theranostic nanocomposite prepared through the electrostatic interaction 
between a cationic tetraplatinated porphyrin complex (PtPor) and negatively charged carbon 
quantum dots (CQDs) for PDT against human cervical carcinoma cells (HeLa). The 
CQDs@PtPor nanocomposite integrates both optical properties of CQDs and the anticancer PDA 
of porphyrins. The PDT efficiency of CQDs@PtPor was stronger than that of the organic 
molecular PtPor, mainly by the enhanced production of 1O2 induced by the presence of CQDs.   
Li et al. 60 have recently revised peptide-modulated self-assembly strategies for supramolecular 
nanotheranostics. Three major assembly schemes were discussed: (1) self-assembly of peptide-
photosensitizers, (2) self-assembly of peptide-anticancer drugs, and (3) multicomponent 
cooperative (PS-anticancer drugs) self-assembly. In the case of supramolecular PS systems, the 
desired strategy is the precise releases of the PS at tumoral cells as induced by some tumor 
microenvironment stimulus (e.g. pH  6.0, heightened glutathione (GSH) level, overexpressed 
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enzymes, and biomarkers) to achieve controlled photosensitizer activation at tumor sites rather 
than normal tissues. 
Non-covalent assembled nanoparticles made with the conjugated polymer poly(9,9-
dioctylfluorene-alt-benzothiadiazole) (F8BT) and the amphiphilic copolymer stabilizer (PS-
PEG-COOH) doped with hydrophobic platinum octaethylporphyrin (PtOEP) as PS were tested 
as theranostic PDT agent in glioblastoma (T98G), colorectal adenocarcinoma (SW480) and 
macrophage (RAW 264.7) cell lines.[62] The non-covalent assembled nanoparticles showed     
 = 0.24 in water, as confirmed by monitoring the NIR phosphorescence emission of 1O2, and 
the PDT treatment was effective in the three types of cells 62.  
Self-assembled micelles and liposomes were formerly used as nano-spherical carriers of 
molecular PS 83, 107, 111, 112. Micelles can carry hydrophobic PS in their hydrocarbon  interior 111, 
while liposomes can encapsulate either hydrophilic drugs within the aqueous regions or lipophilic 
molecules within the lipid bilayers 107. Liposomes were used as delivery systems for 5-
aminolevulinic acid (5-ALA), a pro-drug for the biosynthesis of the potent endogenous 
photosensitizer protoporphyrin IX (PpIX) in neoplastic cells, and the synthetic lipophilic 
temoporfin (mTHPC), for PDT of superficial skin lesions 107. Liposomes bearing PS enhance 
penetration and accumulation of the PS in the skin compared with free molecules, leading to 
higher PDT efficacy and enable topical applications for deep and hyperkeratotic skin lesions. 
Moreover, PDT-driven by liposomes reduced the absorption of the PS into systemic circulation 
compared with the free drug, minimizing the risk of generalized photosensitivity. 
Recently, Xu et al. 108 showed a study of various PS such as benzoporphyrin monoacid ring A 
(BPD), tetraphenylporphinesulfonate (TPPS4), and sodium 4-[2-[(1E,3E,5E,7Z)-7-[1,1-
dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-
dimethylbenzo[e]indol-3-ium-3-yl]butane-1-sulfonate (ICG) targeted with polyethyleneglycol 
(PEG) attached to 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) nanoliposomes (50-100 
nm). In vitro studies showed that BDP encapsulated in PEGylated liposomes (LBDP) had an 
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increase in the efficiency of PDT and greater destruction of blood vessels in tumor tissues 
compared to free BPD. The in vivo localization of the supramolecular PS in tumor-bearing mice 
was performed by both fluorescence imaging (FLI) and photoacoustic imaging (PAI) dual-
model. This multifunctional theranostic agent has exhibited its potential for clinical 
translatability since liposomal encapsulation of PS is the most popular clinically accepted 
nanosized drug delivery strategy. 
The use of semiconductor-based PS like titanium dioxide (TiO2) for PDT applications is strongly 
restricted by the low penetration of UV light into the tissues. Despite TiO2 shows minimal dark 
cytotoxicity, it needs UVA light for ROS generation (e.g. the stronger oxidant HO•). However, 
this limitation can be overcome by using NIR two-photon excitation through upconversion 
energy processes using lanthanides 113. Within this framework, Hou et al.[84] presented a novel 
NIR light-activated photosensitizer for PDT based on TiO2-coated upconversion nanoparticle 
(UCNP) core-shell nanocomposites (UCNPs@TiO2 NCs), using a 
NaYF4:Yb3+,Tm3+@NaGdF4:Yb3+ core/shell. The UCNPs can efficiently convert NIR light to 
UV emission, corresponding to the TiO2 shells absorption region. The nanocomposite is able to 
generate intracellular ROS under NIR irradiation, decreasing the mitochondrial membrane 
potential to release cytochrome c into the cytosol and then activating caspase 3 to induce cancer 
cell apoptosis. Thus, the combination of penetrating NIR radiation with efficient light-triggered 
ROS generation is a powerful weapon for cancer cell destruction. 
Mesoporous silica nanoparticles (MSNs) functionalized with amine groups were used as a 
support to build up a layer-by-layer (LbL) supramolecular structure for tumor theranostic 
application. Multilayer coated MSNs (MCMSN) were obtained by alternative sequential 
adsorption of 1) hyaluronic acid (HA) with β-cyclodextrin (CD) and 2) 5, 10, 15, 20 - tetrakis (4-
sulfonatophenyl) - porphyrin (TPPS4) onto the nanoparticles 69. Then, tirapazamine (TPZ) was 
introduced due to its cytotoxicity toward tumoral cells, obtaining the nanoplatform 
(TPZ@MCMSN). Finally, the integrated TPZ@MCMSN-Gd3+ theranostic agent was formed by 
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a chelation reaction with gadolinium-III (Gd3+). TPZ@MCMSN-Gd3+ was tested in SCC-7 
(Squamous cell carcinoma), MCF-7 (human breast adenocarcinoma), and COS7 (African green 
monkey kidney fibroblast) cell lines. The developed TPZ@MCMSN-Gd3+ supramolecule 
showed several advantages, such as dual-model imaging (NIR fluorescence and MR) guidance, 
effective tumor targeting, and efficient tumor growth inhibition by enhanced ROS production.  
The correlation between the photobiological and photophysical properties of the organometallic 
compounds of Ru(II) with the extent of the π conjugation of the cyclometalation ligand was 
investigated 103. Three of the organometallics derived from non-π-expansive cyclometalating 
ligands presented dark cytotoxic to cancer cells, which was not appreciable amplified by light 
exposure. On the other hand, the Ru(II) organometallic system derived from a π-expansive 
cyclometalating ligand, such 4,9,16-triazadibenzo[a,c]napthacene (pbpn), was completely non-
toxic to cells in the dark, but photo-toxicity to cancer cells increased with a moderate light 
treatment. In addition to excellent its photocytotoxicity, this compound displayed intense green 
intracellular fluorescence.  
Zhang et al. 104 reported that nanoscale supramolecular network formed by co-assembly of the 
amphiphilic amino acid 9-fluorenylmethyloxycarbonyl-L-leucine (Fmoc-L-L) and ionic 
manganese (Mn2+) to encapsulate Ce6. The obtained bio-metal-organic nanoparticles exhibit a 
high Ce6 loading capability, inherent good biocompatibility, robust stability and smart 
disassembly in response to glutathione (GSH). The cooperative assembly of the multiple 
components is synchronously dynamic in nature and enables enhanced PDT to damage tumor 
cells and tissue by efficiently delivering of Ce6 via the competitive coordination of GSH with 
Mn2+. Real-time in vivo evaluation of the antitumor effect was done by MRI through the long-
term intracellular biochelation of Mn2+. 
 An interesting combination of covalent and supramolecular chemistry for efficient 
antitumoral activity was reported by Ren et. al. 101 with the development of a nanosized 
supramolecular system formed by hyaluronic acid (HA) as carrier polymer with Ce6 as PS 
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covalently linked by an adipic dihydrazine bridge, and the anticancer drug doxorubicin (DOX) 
bound by non-covalent interactions. Despite the nanocomposite HA-Ce6 (DOX) could 
specifically bind to A549 cells through the CD44-HA receptor, it showed no PDA due to Ce6 
molecular crowding. The study of cellular uptake and distribution of HA-Ce6 (DOX) by confocal 
fluorescence microscopy showed that, under acidic conditions and enzymatic stimulation, both 
Ce6 and DOX drugs were quickly released inside A549 cells, improving the therapeutic effect 
for individual photodynamic or chemotherapy with free Ce6 or DOX, respectively. Thus, the pH-
responsive nanocomposite resulted in a potent anticancer theranostic agent 101.  
 
5. Antimicrobial supramolecular PS  
The increasing antibiotic resistance developed by the microorganisms 72-74, 89, together with some 
significant drawbacks of molecular PS for the application of APDT in clinical treatments, like 
their lack of selectivity and photobleaching, accelerated the application of supramolecular PS in 
APDT as a new alternative for the local treatment of infections as well as for disinfection of 
different surfaces and materials 20, 35, 39, 41, 65, 92, 114-117. 
As well as for cancer PDT applications, self-assembled polymeric micelles and liposomes have 
been successfully used as nanocarriers for the delivery of PSs molecules into microbial cells, as 
they can prevent PS aggregation and preserves its photophysical properties 111, 112, 114.  
Poly (β-amino ester)s with pH buffering capacities were recently employed for the encapsulation 
of Ce6 in charge-conversion nanoparticles, resulting in an efficient targeting and photodynamic 
inactivation of pathogenic bacteria in a weakly acidic urinary tract infection environment 118. 
Surface charge switching on the nanoparticles conferred them an enhanced recognition towards 
Gram (+) and Gram () bacteria (S. aureus and E. coli, respectively). Moreover, the nanoparticles 
yielded efficient ROS photo-production leading to significant in vitro antibacterial effect, with 
increased minimum inhibitory concentration (MIC) values when compared to free Ce6, but with 
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low systemic cytotoxicity 118. Ce6 grafted onto α-cyclodextrin (α-CD) was also used for selective 
targeting and photodynamic inactivation of P. aeruginosa and methicilin-resistant 
Staphylococcus aureus (MRSA) biofilms towards the formulation of bacteria-targeted PS 
delivery polymeric micelles. Selectivity was achieved by the covalent bounding of antimicrobial 
peptide Magainin I to PEG, then exploiting α-CD/PEG supramolecular assembly by host-guest 
complexation 119. 
An amphiphilic calix[4]arene was utilized for the formation of micellar-like nanocontainers ca. 
40 nm in diameter to encapsulate hydrophilic and hydrophobic phthalocyanine and porphyrin 
derivatives, respectively 120. In aqueous solutions, the hydrophilic phthalocyanine showed self-
aggregation with consequent changes on its spectral properties precluding its use as PS, while 
the hydrophobic porphyrin derivative was insoluble and photochemically inactive under these 
conditions. However, in the presence of the amphiphilic calix[4]arene micellar-like 
nanocontainers, both PS@calixarene nanoassemblies showed high quantum yields of 1O2 
photogeneration and remarkable visible light-induced inactivation of S. aureus and P. 
aeruginosa, representative Gram (+) and Gram () bacteria, respectively 120. 
Metallic nanoparticles (MNP), e.g. Au, Ag, and Pt, have been extensively used for the 
conjugation, coating or loading of PSs for their application in APDT 114. As MNP have 
antimicrobial activities themselves 121, they can act synergistically with the PS through PDA for 
the inactivation of microbial pathogens. Gold NP (AuNPs) obtained from green-synthesis using 
Aloe vera leaf extracts and conjugated with the phenothiazidium dyes MB and toluidine blue O 
(TBO) as PSs showed photodynamic inactivation activity when tested against both planktonic 
and biofilm C. albicans populations 122. Moreover, in vivo experiments in mice demonstrated the 
ability of AuNP@MB and AuNP@TBO conjugates to suppress superficial skin as well as oral 
C. albicans infection, suggesting their potential application on APDT of cutaneous and 
nosocomial  infections 122. Other formulations comprising non-covalent conjugates of MB and 
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AuNPs also showed inhibitory effect over MRSA biofilms and S. aureus isolates from impetigo 
lesions, when irradiated with a red laser (660 nm) 123, 124. 
A nanocomposite formed by conjugating the phenothiazidium dye TBO with AgNPs 
(AgNP@TBO) was tested for the photo-sensitized inactivation of Streptococcus mutans 125. The 
resulting AgNP@TBO composites showed a higher photo-toxicity against S. mutans biofilm than 
the isolated TBO, as it was evidenced by an increased uptake of propidium iodide and by the 
leakage of cellular constituents. Fluorescence spectroscopic studies were conducted to confirm 
that photo-toxicity corresponded to a type I mechanism, with the generation of HO• as the main     
ROS 125. 
A large variety of supramolecular formulations involved the association of PSs with synthetic or 
naturally occurring polymers to yield diverse structured photo-active materials, such as 
polymeric nanoparticles, hydrogels, antimicrobial coatings, or surfaces 41, 51, 65, 66, 114, 126, 127. 
Chen et al. 50 proposed a double-advantageous strategy for biofilm elimination based on 
degradable polymers. On one hand, high local concentrations of an organic PS are achieved by 
its binding to a supramolecular photodynamic polymer through host-guest interactions. Besides, 
after light-induced inactivation of the microorganism, the PS can be detached by competition 
with cucurbit[7]uril, favoring polymer degradation, and thus hindering the progression of drug 
resistance 50. 
Manjón and co-workers employed porous silicone as a support for the immobilization of two 
different Ru(II) complexes (RDP2+ and RDB2+) by hydrophobic interactions 128. The resulting 
PS-doped porous silicon materials (RDP/pSil and RDB/pSil) yielded increased 1O2 lifetimes 
compared to those of PSs in water, and were effective for waterborne Enterococcus faecalis 
photodynamic inactivation using a lab-scale solar simulator or a solar photoreactor as 
illumination sources. After sunlight irradiation, reloading of RDP/pSil with free RDP2+ resulted 
in even higher photodynamic efficiencies than the unused material, which was explained in terms 
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of the aggregation of the silicone-supported photosensitizer on pSil surface, as evidenced by 
photochemical characterization 128. On a later work of the same group, RDP/pSil was compared 
with silicon-supported pristine C60-fullerene or its derivative 1-(4-methyl)-piperazinylfullerene 
(MPF), for their photodynamic water solar disinfection abilities 129. C60/pSil showed poor photo-
induced antibacterial activity due to fullerene aggregation, which results in a negatively charged 
surface. However, the positively charged MPF fullerene derivative was not effective either, 
because the C60 structural modification introduced led to lower 1O2 generation efficiency 129.  
Mesoporous silica nanoparticles (MSNP) functionalized with either amino- or mannose- moieties 
were reported as MB delivery systems for APDT 130. Loading of MB into the MSNPs was driven 
by electrostatic interactions, and two populations of the dye were differentiated according to its 
location on the outer surface of the MSNPs or on the walls of the inner mesopores, as suggested 
by time-resolved spectroscopic studies. Both MSNPs showed photo-inactivation activities 
similar to free MB when tested against E. coli and P. aeruginosa 130. 
A sort of polymer-based structure that has been widely explored for the immobilization of PSs is 
represented by hydrogels, which consist of three-dimensional networks made of cross-linked 
water-soluble polymers 114. Some shared characteristics of these platforms are their high porosity, 
biocompatibility, biodegradability, and flexible shape 114. For example, an anti-infective 
intraocular lens were developed by immobilization of a cationic porphyrin on the surface of 
hydrogels made of acrylate co-polymers. The incorporation of the porphyrin resulted in a great 
reduction of bacterial adhesion on the material 131. 
The development of antimicrobial surfaces involving PSs loaded on polymeric matrices was 
exploited as a healthcare infection prevention strategy. Cahan et al. reported the physical 
immobilization of RB, TBO, or MB by scattering a mixed powder of poly(vinylidene fluoride) 
(PVDF) and PSs onto a polyethylene sheet, and further pressing with a heating press device 41. 
This procedure yielded hydrophobic surfaces with antibacterial photodynamic properties as 
demonstrated by the reduction of E. coli and S. aureus CFUs by >4 logs when illuminated with 
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a fluorescent lamp during 6-24 h 41. More recently, a photodynamic spray coating was formulated 
by taking advantage of the host-guest interaction between β-cyclodextrin and MB, which 
prevented MB aggregation and resulted in a material with high 1O2 photogeneration efficiency 
with low PS density 132. 
An antimicrobial coating with combined virucidal and bactericidal activities was obtained by the 
immobilization of C70 fullerene and AgNPs into polystyrene-block-poly- 4-vinylpyridine (PS-
P4VP) templates, yielding photo-active thin films 133. This nanocomposite presents two distinct 
nanoscale functional domains as C70 is preferentially integrated into PS block domains (due to 
speculated π−π interactions), whereas AgNPs are formed in situ in P4VP domains. The 
significant amounts of 1O2 generated by visible-light activation of C70, together with the Ag+ 
release properties, allowed a synergistic inactivation of both E. coli and PR772 bacteriophage 
133.  
Biopolymer-based nanoparticles, mainly chitosan and cellulose, have shown to be a very 
advantageous PSs delivery agent in APDT due to their biocompatibility, stable formulation, 
versatility and generally easy preparation 134. Chitosan can be isolated from the chitin 
exoskeleton of crustacea and is structurally composed of poly(D-glucosamine) chain. Due to its 
protonated amino groups, chitosan has an intrinsic antimicrobial activity that can be enhanced 
by covalent or non-covalent association with different bioactive compounds, among which are 
PS molecules for APDT applications. Recently, Castro and co-workers reported the ability of 
porphyrinic-chitosan films to inhibit Listeria innocua attachment and prevent subsequent biofilm 
formation 127.  
Several works have reported the application of PS-chitosan hydrogels on topic APDT for wound 
infections, alone or in association with other components, such as 
hydroxypropylmethylcellulose, to improve the mechanical properties of the gels. Chitosan 
hydrogels were combined with PSs like MB or TBO for APDT against both planktonic and 
biofilm-forming pathogens 134, 135. 
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Supramolecular structures involving cellulose association with PSs have been explored in 
multiple configurations for APDT applications. For example, photo-active antimicrobial 
cellulosic fabrics were obtained by embedding the polymeric material with porphyrins, which 
resulted to be immobilized both by electrostatic and covalent interactions, as confirmed by 
diffuse reflectance (UV-Vis) spectroscopy 126. Immobilization of cationic zinc phthalocyanine 
(ZnPc) derivatives on the negatively-charged surface of sulfated cellulose nanocrystals (CNC) 
by electrostatic interactions, yielded hybrid structures with photodynamic inactivation properties 
that outcome those observed for the free ZnPc 51. Both PS concentrations and light doses applied 
for the photodynamic inactivation of S. aureus and E. coli were one to two orders of magnitude 
lower than those reported in the literature for similar but covalently linked porphyrin-based 
systems 136, 137. Interestingly, the ZnPc@CNC composites in aqueous solution did not 
photogenerate 1O2, suggesting that the observed efficient APDT relies on the transfer of ZnPc 
from the CNC surface to the microorganism, standing out the advantage of a non-covalent 
supramolecular strategy 51. 
Carbon-based nanomaterials such as graphene, carbon nanotubes, fullerenes, carbon dots, and 
mesoporous carbon nanoparticles have been used for APDT applications either as PSs carriers 
or as nanomaterials with inherent photosensitizing properties. Akbari et al. 138 demonstrated the 
enhanced PDA of indocyanine green (ICG) conjugated with graphene oxide (GO), if compared 
with ICG alone 138. The conjugate ICG@GO, in which ICG was loaded on the surface of GO by 
strong π–π stacking and hydrophobic interactions, not only showed a 1.3 more effective APDT 
activity against E. faecalis biofilms but also presented some advantages for endodontic 
applications, such as its cost-effectiveness and the much lower dye concentrations needed, with 
concomitantly reduced toxicity. A later work from the same group reported that nanocomposites 
of carnosine-GO decorated with hydroxyapatite had a better ICG loading capacity and longer 
stability than the conjugates prepared with GO alone 139.  
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Multi-walled carbon nanotubes (MWCNT) have been also utilized as delivery vehicles of 
toluidine blue (TB) for the efficient photo-inactivation of P. aeruginosa and S. aureus both in 
planktonic cultures and biofilms 140. The nanocomposite MWCNT@TB allowed the gradual 
releases of the dye and led to a greater APDT efficiency when compared to free TB 140. 
 
6. Conclusions 
In this review, we have presented several supramolecular strategies addressed to overcome some 
of the limitations of molecular photosensitizers (PS) for photodynamic therapy (PDT) and 
antimicrobial photodynamic therapy (APDT) applications.  
Typically, those supramolecular strategies included nanostructured PS self-assemblies, PS co-
assemblies with antibiotics or anticancer drugs, and PS non-covalently and covalently attached 
with polyelectrolytes, biopolymers, and nanoparticles together with other additional materials. 
The main goal is to regulate ROS generation for specific and efficient anticancer or antimicrobial 
therapies, with a focus on the increment of ROS generation at tumor cells or tissue lesions, and 
also taking advantage of known anomalies in tumoral cells and tissues to triggering ROS 
generation with the light stimulus. 
As mentioned through the review, the use of nano/micro-sized supramolecular systems for 
emerging photodynamic applications against multi-drug resistant pathogens and in the 
theranostic application in tumors became a powerful tool, since supramolecular PS systems can 
be designed with very high selectivity to target either tumor or pathogen cells, and with poor or 
null toxicity for normal cells. Also, in the field of theranostic treatments, a large variety of optical 
and non-optical monitoring signals can be obtained, allowing a large variety of tracking non-
invasive methods. Nevertheless, most supramolecular PS systems are still in the initial 
development stages and their safety in animals has not been fully evaluated. Therefore, before 
clinical applications, the safety issues of supramolecular PS should be fully addressed.   
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Advanced or interested readers can find extra information in recent comprehensive reviews on 
both PDT and APDT application fields 16, 17, 20, 31, 32, 37-40, 54, 65, 66, 68, 92, 93, 105, 197, 114. 
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